{"path":"Images/Pasted image 20240225133245.png","text":"SUCCINYLCHOLINE Authors: Reviewers: Billy Sun Joseph Tropiano Melinda Davis, MD s':fr\":;‘;';\"c‘:'?: Malignant Hyperthermia . \" (See Slid Succinylcholine structure (see Slide) (Depolarizing ‘—lﬁ Neuromuscular Blocker) Agonist at nicotinic ACh Agonist at nicotinic receptors in muscles receptors in Abbreviations 1 parasympathetic ACh — Acetylcholine . ganglia, sympathetic i Generates action ganglia; and izl muscarinic receptors Quick Facts [l in SA node of heart 1° Indication = Skeletal muscle . paralysis to allow tracheal WIEEfi ety & 5 acetylcholinesterase intubation with the : advantage of faster onset (el () :3?2761.75}) tahnd shorter duration i Fasciculation Paras!(;:catthetlc e < - ; i thaninon Continuous end-plate (high dose de lepolarizing neuromuscular ene (low dose : : : depolarization ; succinylcholine) blocking agents i succinylcholine) o Myalgia v v Eot=piidunienateo ey Inactivation of sodium J Heart rate 1 Heart rate Contractili Contractilit Metabolism & Excretion = channels iContractlity] facorociity 4 Catecholamine redistribution and metabolism S Priseudociioline Tarass ln Prevention of Serum K (esp. in blood plasma and liver e bt repolarization and patients with muscle No reversal of succinylcholine \"‘dd\"‘°“a’_a“\"°\" trauma/t ‘:f_l'_‘e’:fam”/ s potentials immot Iza ion) Contraindicated in patients ' with traumatized, denervated, Skeletal muscle Hyperkalemia L, Cardiat e reat or immabilized muscles due to paralysis risk of cardiac arrest from hyperkalemia. Legend: Pathophysiology Mechanism _Sign/Symptom/Lab Finding Complications | Published March 3, 2018 on www.thecalgaryguide.com","libVersion":"0.3.2","langs":"eng"}